CellChorus

Our mission is to enable pharmaceutical and biotech companies to bring more antibody therapies to patients. Using AI and massively parallel experimentation, we design antibodies that precisely bind the disease target at the right location, while minimizing manufacturability and toxicity risks. We are a well-funded, revenue-generating, bilingual company of wet- and dry-lab scientists, and are founded by AI and protein design experts from Harvard University.

shared extracted concept terms: biotech, companie; shared product terms: parallel, therapie, antibodie, companie; shared product theme: health and clinical care, sales and marketing; shared affiliation: Y Combinator

Sigma Genetics develops devices that can deliver DNA, RNA, and other charged molecules into cells by using magnetic fields. When compared to conventional electroporation, this technique has several key advantages, which include: the absence of arcing, the ability to scale, and the benefit of being non-invasive for in vivo applications. This platform technology can be applied to a wide range of applications- cell therapies, cancer drug delivery, DNA vaccines, biopharma manufacturing, and cosmetic

shared extracted concept terms: biopharma; shared product terms: cell, develop, deliver, therapie; same category: Developer tools; shared affiliation: Y Combinator

Andson Biotech helps pharmaceutical companies measure difficult to detect chemicals that they need to measure while developing and manufacturing drugs like cell-therapies or biologics. Drug companies want to use our technologies to get fast and accurate chemical measurements they do thousands of times per day for drug development and quality control.

shared extracted concept terms: companie; shared product terms: biotech, companie, develop, cell; same category: Developer tools; shared affiliation: Y Combinator

Maven Bio is a 10-person seed-stage team in Boston building the market intelligence layer for life sciences AI. Three of the top 10 pharma companies are onboarded, and we have 20+ enterprise accounts across pharma, consulting, and investing. Customers report a 40% reduction in low-level analytical work. We are growing fast and heading for a Series A. Our buyers are senior BD, CI, Strategy, and Investing leaders.

shared extracted concepts: customers; shared product terms: intelligence, customer, top, companie; shared product theme: sales and marketing; shared affiliation: Y Combinator

Launched in February 2021, Jasper is an AI content platform that helps creators and companies of all types expand their creative potential. Over 105,000 active customers are using Jasper to break through writer’s block, repackage their content, create original art, and adjust writing for language and tone. The interest in AI continues to grow and we are at the forefront of teaching the world how to leverage artificial intelligence as a creative partner. We are building teams that will pioneer th

shared extracted concept terms: companie, customer; shared product terms: artificial, intelligence, over, customer; shared product theme: sales and marketing; shared affiliation: Y Combinator

Fabraix builds state-of-the-art AI red-teaming agents that continuously detect security vulnerabilities in customer-facing AI. Our product, Nyx, has already found vulnerabilities in agents at dozens of Fortune 500 companies. On AgentHarm, the leading benchmark for offensive AI security, Nyx achieved a 78% attack success rate, compared with 67% for GPT-5.6 Sol. Companies usually pay for penetration tests one project at a time. They select which systems to include, give a team a few weeks to find

shared extracted concept terms: companie; shared product terms: time, customer, rate, succes; shared product theme: sales and marketing; shared affiliation: Y Combinator